Glycemia Reduction Approaches in Diabetes Study Seeks Volunteers
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study from the Diabetes Research Group, VA Puget Sound Health Care System and University of Washington
Most people with diabetes need drugs to help control blood sugar. Metformin is the usual first-line drug treatment for diabetes. Eventually, most people treated with metformin need a second drug. The American Diabetes Association recommends 4 potential second-line treatments for people who need two drugs. It is not clear which of the four is best for controlling diabetes over the long- term when combined with metformin. Each has advantages and disadvantages.
The goal of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
(GRADE Study) is to try to determine which treatment for Type 2 Diabetes is best.
- Adult over the age of 30 (20 if Native American)
- Had Diabetes less than 5 years
- Only taking Metformin
- Willing to take a second diabetes drug
Screening visit will be conducted at the UW Diabetes Care Center
Study visits will be conducted VA Puget Sound Health Care System
Compensation will be provided in the form of medical treatment, $25 for every visit completed (not screening and run-in) and free study medications for up to 7 years.
Learn more about the study at: http://grade.bsc.gwu.edu, or to set up a screening interview please call the University of Washington Diabetes Care Center at 206-598-4978.
Principle Investigators for this study are Dace Trence, MD and Kristina Utzschneider, MD.